Current Trials

Suffering from Nail and Scalp Psoriasis?

Eli Lilly is conducting a US-Based Observational Study of Nail and Scalp Psoriasis Improvement in Patients Treated with Ixekizumab (Taltz) To participate in your local study,

Suffering from Atopic Dermatitis?

Eli Lilly and Company are conducting a Long-term Study to Assess the Safety and Efficacy of xxxxxxxxxxx in Patients With Moderate-to-Severe Atopic Dermatitis. To participate

Do You Want To Boost Your Business?

drop us a line and keep in touch

Call us, write us, or knock on our door.

Lorem ipsum dolor sit amet, consectetur adiop iscing elit, sed do eiusmod tempor inci didunt ult labore et dolore magna aliqua.